N-Methyl-1-(3-(m-tolyl)-1,2,4-oxadiazol-5-yl)methanamine hydrochloride

Catalog No. :
ACWQSH235
CAS No. :
890324-18-2
Molecular Formula :
C11H14ClN3O
Molecular Weight :
239.71

IUPAC Name:N-methyl-1-(3-(m-tolyl)-1,2,4-oxadiazol-5-yl)methanamine hydrochloride

N-Methyl-1-(3-(m-tolyl)-1,2,4-oxadiazol-5-yl)methanamine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$127.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Methyl-1-(3-(m-tolyl)-1,2,4-oxadiazol-5-yl)methanamine hydrochloride
IUPAC NameN-methyl-1-(3-(m-tolyl)-1,2,4-oxadiazol-5-yl)methanamine hydrochloride
MDL No.MFCD07363364
Molecular FormulaC11H14ClN3O
Molecular Weight239.71
SMILESCC1=CC(C2=NOC(CNC)=N2)=CC=C1.[H]Cl
InChI KeyRCZQOHWISOXENI-UHFFFAOYSA-N
SynonymN-METHYL-1-[3-(3-METHYLPHENYL)-1,2,4-OXADIAZOL-5-YL]METHANAMINE HYDROCHLORIDE;N-METHYL-N-((3-(3-METHYLPHENYL)-1,2,4-OXADIAZOL-5-YL)METHYL)AMINE;UKRORGSYN-BB BBR-055326;N-methyl-1-[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]methanamine hydrochloride(SALTDATA: FREE);N-Methyl-1-[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]methanamine;CHEMBRDG-BB 9022460;N-Methyl-1-(3-(m-tolyl)-1,2,4-oxadiazol-5-yl)methanamine hydrochloride;N-methyl-1-(3-(m-tolyl)-1,2,4-oxadiazol-5-yl)methanamine
CAS No.890324-18-2

Synthetic Route by SureRoute

1. ACWQSH235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEWMQ843 route compound structure diagram
    ACEWMQ84350737-31-0 In Stock
  4. Then
  5. ACWQSH235 route product structure diagram
    ACWQSH235890324-18-2
Inquiry

2. ACWQSH235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWQSH235 route product structure diagram
    ACWQSH235890324-18-2
Inquiry

Comments (0)